MYGN
Myriad Genetics Inc.
$6.37
+$0.15(+2.41%)
38
Overall
--
Value
33
Tech
44
Quality
Market Cap
$540.59M
Volume
2.58M
52W Range
$3.76 - $29.30
Target Price
$7.42
EPS Estimates Overview
| Current Quarter | $-0.1 | Next Quarter | $-0.08 |
| Current Year | $-0.4 | Next Year | $-0.29 |
| QoQ Growth | +20.0% | YoY Growth | +27.5% |
| 3Y EPS CAGR | -41.7% | Target Price | $7.42 |
| Consensus | Buy | Upside | +16.5% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MYGN | $6.37 | +2.4% | 2.58M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |